⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVBP News
ArriVent BioPharma, Inc. Common Stock
Form 8-K
sec.gov
AVBP
Form 8-K
sec.gov
AVBP
ArriVent BioPharma Reports First Quarter 2026 Financial Results
globenewswire.com
AVBP
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
globenewswire.com
AVBP
Form 8-K
sec.gov
AVBP
ArriVent to Present Two Preclinical Posters on the EGFR Inhibitor Firmonertinib and on the Novel dual-target MUC16/NaPi2b Tetravalent ADC ARR-002 at the 2026 AACR Annual Meeting
globenewswire.com
AVBP
Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026
businesswire.com
AVBP
Form 8-K
sec.gov
AVBP
ArriVent BioPharma Reports Full Year 2025 Financial Results
globenewswire.com
AVBP
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
AVBP
SMMT
MRUS
MRK
GNPX
CGEM
ABBV
BMY
BDTX
LTRN
PFE
JNJ
LLY